Wealth Enhancement Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.31M | Sell |
82,607
-11,493
| -12% | -$600K | 0.01% | 962 |
|
|
2025
Q1 | $3.2M | Buy |
94,100
+66,789
| +245% | +$2.27M | 0.01% | 1017 |
|
|
2024
Q4 | $1.07M | Sell |
27,311
-2,930
| -10% | -$115K | ﹤0.01% | 1489 |
|
|
2024
Q3 | $1.42M | Sell |
30,241
-1,657
| -5% | -$77.8K | ﹤0.01% | 1216 |
|
|
2024
Q2 | $1.72M | Buy |
31,898
+18,239
| +134% | +$985K | ﹤0.01% | 1050 |
|
|
2024
Q1 | $931K | Sell |
13,659
-492
| -3% | -$33.5K | ﹤0.01% | 1269 |
|
|
2023
Q4 | $886K | Buy |
14,151
+3,781
| +36% | +$237K | ﹤0.01% | 1218 |
|
|
2023
Q3 | $471K | Buy |
+10,370
| New | +$471K | ﹤0.01% | 1459 |
|